Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
02 3Aspen Oss B.V.
03 1Ambiopharm, Inc.
04 1Aurobindo Pharma Limited
05 1BCN PEPTIDES SA
06 1CHEMI SPA
07 1Darmerica, LLC
08 14Hemmo Pharmaceuticals Pvt. Ltd
09 1MEDISCA Inc.
10 22Piramal Pharma Limited
11 1PolyPeptide Laboratories, Pvt. Ltd.
12 1Professional Compounding Centers of America
13 1SUN PHARMACEUTICAL INDUSTRIES, INC.
14 3Takeda Pharmaceutical Company LTD
15 8Takeda Pharmaceutical Company Limited
01 2LEUPROLIDE
02 1LEUPROLIDE ACETATE
03 2Leuprolide
04 43Leuprolide Acetate
05 1Leuprorelin
06 11leuprolide acetate
01 2India
02 1Italy
03 11Japan
04 3Netherlands
05 1Spain
06 2Switzerland
07 39U.S.A
08 1United Kingdom
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0002
Start Marketing Date : 2001-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aspen API. More than just an API.
NDC Package Code : 60870-0425
Start Marketing Date : 1996-04-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aspen API. More than just an API.
NDC Package Code : 60870-0471
Start Marketing Date : 2014-06-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aspen API. More than just an API.
NDC Package Code : 60870-0472
Start Marketing Date : 1996-04-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11532-1451
Start Marketing Date : 1989-01-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (7.5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1452
Start Marketing Date : 1993-04-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1453
Start Marketing Date : 1993-04-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (15mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1454
Start Marketing Date : 1993-04-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (7.5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1455
Start Marketing Date : 2011-06-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (45mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1450
Start Marketing Date : 1990-10-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (3.75mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 13 companies offering Leuprolide Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
